ArticlePloS one2023

Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.

Thailin Lao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.